Home / Business and Economy / Court Orders $245M Payout Over DNA Tech Patents
Court Orders $245M Payout Over DNA Tech Patents
24 Aug
Summary
- Guardant Health must pay over $245.2 million in a court ruling.
- The payment is for infringing patents on DNA sequencing technology.
- TwinStrand Biosciences and University of Washington are recipients.
A U.S. court has issued a ruling requiring Guardant Health to pay over $245.2 million. This substantial award is designated for TwinStrand Biosciences and the University of Washington.
The court determined that Guardant Health infringed upon patents that cover DNA sequencing technology. TwinStrand Biosciences announced this development on Monday, marking a significant outcome in the legal dispute.
The case highlights the importance of intellectual property rights within the rapidly advancing field of biotechnology and genetic analysis.
Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
